Additionally, no significant difference in serum IL-27α levels was observed between steroid-treated and untreated patients with TAO (p = 0.186; data not shown), suggesting that recent glucocorticoid therapy did not substantially influence circulating IL-27α concentrations in this cohort. The gene discussed is IL27; the disease is thromboangiitis obliterans.